{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Anemia%2C+Hemolytic%2C+Autoimmune&page=2", "query": { "condition": "Anemia, Hemolytic, Autoimmune", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Anemia%2C+Hemolytic%2C+Autoimmune&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T09:22:29.222Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00001630", "title": "Treatment of Autoimmune Thrombocytopenia (AITP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autoimmune Disease", "Autoimmune Hemolytic Anemia", "Thrombocytopenia" ], "interventions": [ { "name": "Isolex 300i", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 29, "start_date": "1997-07-21", "completion_date": "2009-06-11", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001630" }, { "nct_id": "NCT04661033", "title": "Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Warm Autoimmune Hemolytic Anemia (wAIHA)" ], "interventions": [ { "name": "Isatuximab SAR650984", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2021-09-09", "completion_date": "2023-06-26", "has_results": true, "last_update_posted_date": "2024-12-05", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04661033" }, { "nct_id": "NCT02612558", "title": "A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Warm Antibody Autoimmune Hemolytic Anemia" ], "interventions": [ { "name": "Fostamatinib 150 mg bid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rigel Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2016-07", "completion_date": "2019-12", "has_results": false, "last_update_posted_date": "2021-07-21", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 31, "location_summary": "Gilbert, Arizona • Tucson, Arizona • La Jolla, California + 27 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02612558" }, { "nct_id": "NCT05096403", "title": "A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cold Agglutinin Disease" ], "interventions": [ { "name": "Pegcetacoplan", "type": "DRUG" }, { "name": "Placebo matching Pegcetacoplan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Swedish Orphan Biovitrum", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2022-10-20", "completion_date": "2024-09-11", "has_results": true, "last_update_posted_date": "2025-10-30", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 5, "location_summary": "Whittier, California • Miami Lakes, Florida • Iowa City, Iowa + 2 more", "locations": [ { "city": "Whittier", "state": "California" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "New York", "state": "New York" }, { "city": "Greenville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05096403" }, { "nct_id": "NCT01276561", "title": "Single Incision Versus Standard Laparoscopic Splenectomy", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hereditary Spherocytosis", "Idiopathic Thrombocytopenic Purpura" ], "interventions": [ { "name": "Single Incision Splenectomy", "type": "PROCEDURE" }, { "name": "Laparoscopic Splenectomy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Children's Mercy Hospital Kansas City", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "18 Years", "sex": "ALL", "summary": "1 Year to 18 Years" }, "enrollment_count": 0, "start_date": "2009-10", "completion_date": "2017-04", "has_results": false, "last_update_posted_date": "2017-02-03", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01276561" }, { "nct_id": "NCT06312644", "title": "Study of Ultomiris® (Ravulizumab) Safety in Pregnancy", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ultomiris-exposed Pregnant/ Postpartum", "Pregnancy", "Paroxysmal Nocturnal Hemoglobinuria (PNH)", "Atypical Hemolytic Uremic Syndrome (aHUS)", "Generalized Myasthenia Gravis (gMG)", "Neuromyelitis Optica Spectrum Disorder (NMOSD)" ], "interventions": [ { "name": "Ultomiris", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 75, "start_date": "2024-12-16", "completion_date": "2034-07-11", "has_results": false, "last_update_posted_date": "2026-04-16", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06312644" }, { "nct_id": "NCT03764618", "title": "A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Warm Antibody Autoimmune Hemolytic Anemia" ], "interventions": [ { "name": "Fostamatinib disodium", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rigel Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 90, "start_date": "2019-04-24", "completion_date": "2022-04-11", "has_results": true, "last_update_posted_date": "2023-05-25", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 26, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 22 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03764618" }, { "nct_id": "NCT06004947", "title": "A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis" ], "interventions": [ { "name": "CCX168", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Rifampicin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2016-01-14", "completion_date": "2016-06-10", "has_results": false, "last_update_posted_date": "2023-08-22", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06004947" }, { "nct_id": "NCT06098755", "title": "The Sequestration of Holistic Stress Management Techniques for Adults", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress, Job", "PTSD", "Hypervigilance", "Hyperthyroidism", "Migraine", "Migraine With Aura", "Immunodeficiency", "Sickle Cell Trait", "Sickle Cell Disease", "Anemia, Sickle Cell", "Anemia", "Fatigue", "Anxiety", "Depression", "Flat Feet", "Lordosis", "TBI (Traumatic Brain Injury)", "Rheumatoid Arthritis", "Arthritis", "Masturbation", "Priapism", "Erectile Dysfunction", "Flight Reaction", "Hypertension", "Sexual Arousal Disorder", "Hemorrhoids", "Fibroid" ], "interventions": [ { "name": "Holistic Medicine (HM)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Goddess Zena I. Jones", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 0, "start_date": "2026-01-26", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 1, "location_summary": "Anchorage, Alaska", "locations": [ { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06098755" }, { "nct_id": "NCT05648968", "title": "A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Warm Autoimmune Hemolytic Anemia (wAIHA)" ], "interventions": [ { "name": "Ianalumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 90, "start_date": "2022-12-30", "completion_date": "2028-12-19", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-06-10T09:22:29.222Z", "location_count": 3, "location_summary": "Farmington Hills, Michigan • Minneapolis, Minnesota • Seattle, Washington", "locations": [ { "city": "Farmington Hills", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05648968" } ] }